ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0986

State-and-County-Level Social Vulnerability Index and Trends in Systemic Lupus Erythematosus-Related Mortality in the U.S

Omer Pamuk1, Ansaam Daoud2, Hasan Cetin3 and Marina Magrey4, 1University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 2Case Western Reserve University/University Hospitals, Akron, OH, 3Cleveland Clinic Cole Eye Institute, Cleveland, OH, 4Case Western Reserve University School of Medicine/University Hospitals, Richfield, OH

Meeting: ACR Convergence 2024

Keywords: Disparities, Mortality, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Epidemiological studies have shown significant health disparities in systemic lupus erythematosus (SLE). The Centers for Disease Control and Prevention (CDC) developed the social vulnerability index (SVI) to identify communities that may be at high risk for specific diseases or events. In this study, we aimed to investigate the relationship between state- and county-level SVI and changes in SLE-related age-adjusted mortality rates (AAMRs) over a 20-year period in the U.S.

Methods: SLE-related AAMR data were obtained from the CDC WONDER. Data were extracted from 1999 through 2020 in two 11-year periods: 1999-2009 and 2010-2020. Additionally, data from both periods were pooled to obtain the SLE-related AAMR over the entire study period. The CDC WONDER algorithm defines cause-specific mortality rates as unreliable with raw counts below 20 for any location.

SVI data for 2009 and 2020 were obtained from the CDC Agency for Toxic Substances and Disease Registry, which ranks every U.S. census tract on social factors using the American Community Survey data. The SVI ranks census tracts on 15 social factors, and further groups them into four related themes: socioeconomic status (SES), housing and transportation (HT), minority status (MS), and household composition (HC). State-level SVI categories were created by computing CDC county-level SVI estimates as weighted aggregates. All states were classified into three categories based on their weighted SVI scores: Tertile 1 (0.10-0.32), Tertile 2 (0.33-0.53), and Tertile 3 (0.54-0.90). Higher SVI scores and tertiles correspond to a higher burden of factors that result in social vulnerability.

Results: Compared to the first and second tertiles of SVI, U.S. states in the third tertile exhibited higher SLE-related average AAMR. Within third tertile states, SLE-related average AAMRs were also notably higher in females, White, and non-Hispanic populations compared to first and second tertiles due to their SVI scores. Among males, SLE-related AAMR was higher in the third tertile states compared to the second tertile (Table 1). There were no significant differences in SLE AAMRs among black and Hispanic populations across states. 

For US counties, AAMR data for SLE was available in only 265 counties from 50 states. We evaluated the relationship between SLE-related AAMR and SVI scores. Our analysis showed that SLE-related AAMRs significantly correlated with SVI scores in these counties (r=0.61, R2=0.38, p< 0.0001). In addition, we analyzed the relationship between SLE-related AAMRs and various SVI sub-categories. SLE-related AAMR  correlated with scores of SES (r=0.65, R2=0.42), HC (r=0.44, R2=0.19), MS (r=0.39, R2=0.15) and HT (r=0.4, R2=0.16) (p values < 0.001).

To analyze changes during the study period, we estimated AAMRs for SLE in two periods (1999-2009 and 2010-2020). We detected a weak inverse correlation between the decline of AAMR and SVI scores (r=-0.21, R2=0.043, p=0.025).

Conclusion: Our study showed that SVI is a good predictive parameter for SLE mortality, especially for female and White SLE patients. In recent two decades, SLE-related mortality declined more prominently in regions with low levels of social vulnerability.

Supporting image 1

Table 1. SLE-related AAMRs in various states by tertile of SVI


Disclosures: O. Pamuk: None; A. Daoud: None; H. Cetin: None; M. Magrey: AbbVie, 2, 5, BMS, 2, 5, Eli Lilly, 2, Novartis, 2, Pfizer, 2, UCB Pharma, 2, 5.

To cite this abstract in AMA style:

Pamuk O, Daoud A, Cetin H, Magrey M. State-and-County-Level Social Vulnerability Index and Trends in Systemic Lupus Erythematosus-Related Mortality in the U.S [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/state-and-county-level-social-vulnerability-index-and-trends-in-systemic-lupus-erythematosus-related-mortality-in-the-u-s/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/state-and-county-level-social-vulnerability-index-and-trends-in-systemic-lupus-erythematosus-related-mortality-in-the-u-s/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology